Another Major Drug Approval for Regeneron

Congratulations to BCW member Regeneron on the approval of an important new drug to help patients with rheumatoid arthritis. The U.S. Food and Drug Administration has approved the human antibody drug sarilumab, developed by Regeneron Pharmaceuticals Inc. in Westchester and its French pharmaceutical partner Sanofi and trademarked as Kevzara, to treat adult patients with moderately to severely active rheumatoid arthritis.
The FDA approval came less than two months after the federal agency approved Regeneron’s and Sanofi’s human antibody dupilumab, marketed as Dupixent, as the first biologic medicine used to treat the debilitating itching and widespread rashes afflicting adults with moderate to severe cases of atopic dermatitis.
More News
As the Business Council of Westchester prepares for its 2026 Annual Dinner: Celebrating Leadership & Legacy, we are proud to recognize the outstanding organizations whose support helps make this signature celebration possible. Our Annual Dinner is an opportunity to bring together Westchester’s business community to celebrate the leaders, organizations and partnerships that continue to shape […]
BCW Members Marist University and IBM today announced a new Innovation Incubator that will prepare students across fields of study to lead in a rapidly evolving digital economy. The incubator, the latest milestone in IBM and Marist’s more than 50-year partnership, includes an IBM z17 mainframe to provide enormous AI computing power on campus for […]
Members of the Business Council of Westchester’s Clean Energy Action Coalition (CEAC) joined Morgan Stanley’s The Future of Energy: Practical Solutions for Key Stakeholders forum on September 17, helping building owners, nonprofits, and real estate leaders navigate a rapidly changing energy landscape. The event at Morgan Stanley’s Purchase auditorium brought together decision-makers from multifamily, commercial, […]
Become A Member
Join the county’s largest and most influential business organization today.
JOIN NOW!
Leave a Comment
You must be logged in to post a comment.